» Articles » PMID: 34211505

Polycystic Ovary Syndrome and Risk of Five Common Psychiatric Disorders Among European Women: A Two-Sample Mendelian Randomization Study

Overview
Journal Front Genet
Date 2021 Jul 2
PMID 34211505
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Observational studies have implied an association between polycystic ovary syndrome (PCOS) and psychiatric disorders. Here we examined whether PCOS might contribute causally to such disorders, focusing on anxiety disorder (AD), bipolar disorder (BIP), major depression disorder (MDD), obsessive compulsive disorder (OCD), and schizophrenia (SCZ). Causality was explored using two-sample Mendelian randomization (MR) with genetic variants as instrumental variables. The genetic variants were from summary data of genome-wide association studies in European populations. First, potential causal effects of PCOS on each psychiatric disorder were evaluated, and then potential reverse causality was also assessed once PCOS was found to be causally associated with any psychiatric disorder. Causal effects were explored using inverse variance weighting, MR-Egger analysis, simulation extrapolation, and weighted median analysis. Genetically predicted PCOS was positively associated with OCD based on inverse variance weighting (OR 1.339, 95% CI 1.083-1.657, = 0.007), simulation extrapolation (OR 1.382, 95% CI 1.149-1.662, = 0.009) and weighted median analysis (OR 1.493, 95% CI 1.145-1.946, = 0.003). However, genetically predicted OCD was not associated with PCOS. Genetically predicted PCOS did not exert causal effects on AD, BIP, MDD, or SCZ. In European populations, PCOS may be a causal factor in OCD, but not AD, BIP, MDD, or SCZ.

Citing Articles

Causal evidence of the relationship between polycystic ovary syndrome and obstructive sleep apnea in European and East Asian populations: a two-sample Mendelian randomization study.

Liu X, He R, Zhu K, Lin Z, Jiang Z, Wu H J Thorac Dis. 2024; 16(11):7372-7382.

PMID: 39678857 PMC: 11635232. DOI: 10.21037/jtd-24-885.


Research trend and hotspots of polycystic ovary syndrome with depression from 1993 to 2024: a bibliometric analysis.

Xie J, Cao Y, Wen Q, Song X, Shi Y, Gao X Front Glob Womens Health. 2024; 5:1468471.

PMID: 39669109 PMC: 11634872. DOI: 10.3389/fgwh.2024.1468471.


Applications of Mendelian randomization in psychiatry: a comprehensive systematic review.

Saccaro L, Gasparini S, Rutigliano G Psychiatr Genet. 2022; 32(6):199-213.

PMID: 36354137 PMC: 9648985. DOI: 10.1097/YPG.0000000000000327.


A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS).

Siddiqui S, Mateen S, Ahmad R, Moin S J Assist Reprod Genet. 2022; 39(11):2439-2473.

PMID: 36190593 PMC: 9723082. DOI: 10.1007/s10815-022-02625-7.

References
1.
Saydam B, Yildiz B . Polycystic Ovary Syndrome and Brain: An Update on Structural and Functional Studies. J Clin Endocrinol Metab. 2020; 106(2):e430-e441. DOI: 10.1210/clinem/dgaa843. View

2.
Davies N, Holmes M, Davey Smith G . Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018; 362:k601. PMC: 6041728. DOI: 10.1136/bmj.k601. View

3.
Martins-Silva T, Vaz J, Hutz M, Salatino-Oliveira A, Genro J, Hartwig F . Assessing causality in the association between attention-deficit/hyperactivity disorder and obesity: a Mendelian randomization study. Int J Obes (Lond). 2019; 43(12):2500-2508. DOI: 10.1038/s41366-019-0346-8. View

4.
Owens S, Purves-Tyson T, Webster M, Weickert C . Evidence for enhanced androgen action in the prefrontal cortex of people with bipolar disorder but not schizophrenia or major depressive disorder. Psychiatry Res. 2019; 280:112503. DOI: 10.1016/j.psychres.2019.112503. View

5.
Wen Y, Wu X, Peng H, Li C, Jiang Y, Su Z . Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis. Breast Cancer Res Treat. 2020; 185(3):799-806. DOI: 10.1007/s10549-020-05973-z. View